Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease

Manuel Rodriguez1, Lydia Alvarez-Erviti, Francisco J Blesa

  • 1Laboratory of Neurobiology and Experimental Neurology, Department of Physiology, Faculty of Medicine, University of La Laguna, La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.es

Neurobiology of Disease
|September 28, 2007
PubMed

Insights

Peripheral bone-marrow-derived cells migrate to the brain in a Parkinson

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Parkinson's disease (PD) involves dopamine (DA) cell degeneration.
  • Microglial activation is a key feature of neurodegeneration in PD.
  • The origin of reactive microglia in PD remains incompletely understood.

Purpose of the Study:

  • To investigate the migration of peripheral bone-marrow-derived cells (BMDCs) to the brain in a mouse model of PD.
  • To determine if BMDCs can cross the blood-brain barrier (BBB) and differentiate into brain cells.
  • To explore the potential role of BMDC-derived cells in PD pathogenesis.

Main Methods:

  • Used a chronic mouse model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP).
  • Injected enhanced green fluorescent protein (GFP)-labeled BMDCs into irradiated mice to track their fate.
  • Analyzed cell migration, differentiation (e.g., CD68, NeuN, GFAP), and gene expression post-MPTP administration.

Main Results:

  • MPTP-induced PD model increased GFP-BMDC penetration across the BBB into DA-rich brain regions.
  • Most infiltrating BMDCs differentiated into microglia (CD68+), exhibiting activated morphology.
  • BMDC infiltration preceded evident DA cell loss and persisted after MPTP withdrawal; no neuronal or astrocyte differentiation observed.

Conclusions:

  • A significant proportion of microglia in this PD model originate from the periphery.
  • Peripheral BMDCs infiltrate the brain and differentiate into microglia during DA neurodegeneration.
  • This BMDC-derived microglial influx may contribute to PD pathogenesis, offering potential therapeutic targets.